Table 10.
Serum tumour marker expression rates stratified by tumour size categories in the entire population of patients with testicular tumours (SE, NS, BT, OM).
| bHCG | AFP | LDH | AFP/bHCG | M371 | |
|---|---|---|---|---|---|
| n/N | n/N | n/N | n/N | n/N | |
| ≤10 mm | 6/87 (6.90%) | 2/87 (2.30%) | 3/87 (3.45%) | 8/87 (9.20%) | 16/75 (21.33%) |
| >10 mm | 202/553 (36.53%) | 116/553 (20.98%) | 122/546 (22.34%) | 241/553 (43.58%) | 309/375 (82.40%) |
| p-value * | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
* Chi-squared test, AFP/bHCG elevation of AFP and/or bHCG; N: number of eligible patients.